22–23 Jul 2026
Heidelberg Congress Center
Europe/Berlin timezone

Reducing Symptom Burden Through Physical Exercise in Melanoma Patients Under Immunotherapy or Targeted Therapy: the RESPECT Trial – First Insights Into an Ongoing Trial

22 Jul 2026, 12:00
1h 15m
Heidelberg Congress Center ( Heidelberg Congress Center )

Heidelberg Congress Center

Heidelberg Congress Center

Czernyring 20 69115 Heidelberg Germany
1 - Scientific Poster Poster Session

Speaker

Simon Basteck (Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen)

Description

Background: Despite survival gains with immune checkpoint and targeted therapies, toxicities and adverse effects—particularly fatigue—impair quality of life in melanoma patients. Although exercise benefits are established in oncology, its integration in melanoma care is underexplored. RESPECT examines whether a supervised hybrid (online/in-person) exercise program reduces fatigue and improves quality of life, cognition, and physical function during adjuvant immunotherapy or targeted therapy.

Methods: The RESPECT trial is a single-center randomized controlled trial at the West German Cancer Center (N=104), allocating patients 1:1 to a 12-week supervised hybrid exercise program vs standard care. The intervention includes online group sessions (2/week), in-person visits (3 during intervention period), and app-guided home training (1/week); each 60-minute session combines aerobic, resistance, and coordination exercises with cognitive elements. Assessments at baseline, post-intervention, and 6-week follow-up include fatigue (FACIT-F), melanoma-specific quality of life (FACT-M), physical activity (BSA questionnaire), physical function (5RM; VO2peak), cognition (MoCA), body composition (BIA), and circulating metabolites/cytokines; EHRs capture treatment exposure and clinical events.

Discussion: To date, n=6 patients have been enrolled (median age 60 years; range 42–73). Based on evidence in other cancers, we hypothesize that regular exercise will reduce fatigue in melanoma. Integrating metabolite and cytokine profiling with patient-reported, cognitive, and performance outcomes will elucidate immunometabolic pathways by which exercise may influence treatment efficacy and toxicity. The patient-centered, digitally supported design addresses varying health, toxicities, digital literacy, and travel distance; individualized prescriptions, app-supported home sessions, and close team contact aim to optimize adherence and safety. Interim feasibility data of approximately 25 patients can be presented at the conference.

Conclusion: If efficacious, this pragmatic model could underpin routine implementation of structured exercise in adjuvant melanoma care.

Disclosure Statement: All authors declare no competing interests.

Keywords

Exercise, Melanoma, Quality of Life

Abstract submitters declaration yes
Conflict of Interest & Ethical Approval yes

Authors

Simon Basteck (Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen) Miriam Götte (University Hospital Essen, West German Cancer Center, 45122 Essen, Germany)

Co-authors

Rebecca Zimmer (Universitätsklinikum Essen (AöR), Zentrum für Kinder- und Jugendmedizin, Kinderheilkunde III) Prof. Lisa Zimmer (Klinik für Dermatologie, Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen) Prof. Elisabeth Livingstone (Klinik für Dermatologie, Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen) Katharina Kaminski (Westdeutsches Tumorzentrum Essen) Catharina Spohr (Westdeutsches Tumorzentrum Essen) Kristina Hardt (Westdeutsches Tumorzentrum Essen) Prof. Alpaslan Tasdogan (Klinik für Dermatologie, Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen) Prof. Mitra Tewes (Palliativmedizin Essen, Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen) Prof. Dirk Schadendorf (Klinik für Dermatologie, Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen)

Presentation materials

There are no materials yet.